CRVS vs PAYC · $1.04B cap vs P/E 33, rev $1.88B
Corvus Pharmaceuticals Inc (CRVS) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
CRVS does not have a complete income-statement cache yet.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
CRVS currently screens at market cap $1.04B. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the CRVS and PAYC stock pages for the full models.
Not investment advice.